Lung diseases triggered by endogenous or exogenous factors have become a major
concern, with high morbidity and mortality rates, especially after the coronavirus disease …

An overly exuberant immune response, characterized by a cytokine storm and uncontrolled
inflammation, has been identified as a significant driver of severe coronavirus disease 2019 …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus
Disease 2019 (COVID-19), which can result in severe disease, often characterised by a …

The mRNA-LNP vaccine has received much attention during the COVID-19 pandemic since
it served as the basis of the most widely used SARS-CoV-2 vaccines in Western countries …

Two important factors affecting the progress of coronavirus disease 2019 (COVID-19)
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are the S …

The continuous threats posed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2), the virus that causes COVID-19, including the emergence of potentially more …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causes acute
coronavirus disease-19 (COVID-19) that has emerged on a pandemic level. Coronaviruses …

Background. The emergence, global spread, and persistence of SARS-CoV-2 resulted in an
unprecedented need for effective antiviral drugs. Throughout the pandemic, various drug …

Background The aim was to elucidate the function of IL‐37 in middle east respiratory
syndrome coronavirus (MERS‐CoV) infection, thereby providing a novel therapeutic strategy …

Although azvudine has become a priority in the treatment of SARS‐CoV‐2, its effectiveness
and safety among COVID‐19 patients who already have chronic respiratory diseases …